These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 10412269

  • 1. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
    Szadowska A, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    Pol J Pathol; 1999; 50(1):9-16. PubMed ID: 10412269
    [Abstract] [Full Text] [Related]

  • 2. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 3. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
    Stefanou DG, Nonni AV, Agnantis NJ, Athanassiadou SE, Briassoulis E, Pavlidis N.
    Anticancer Res; 1998 Sep; 18(6B):4673-81. PubMed ID: 9891539
    [Abstract] [Full Text] [Related]

  • 4. Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
    Stefanaki K, Tzardi M, Kouvidou C, Chaniotis V, Bolioti M, Vlychou M, Zois M, Kakolyris S, Delides G, Rontogianni D, Georgoulias V, Kanavaros P.
    Anticancer Res; 1998 Sep; 18(4A):2403-8. PubMed ID: 9703886
    [Abstract] [Full Text] [Related]

  • 5. Mdm2 and the p53 pathway in human pituitary adenomas.
    Suliman M, Royds J, Cullen D, Timperley W, Powell T, Battersby R, Jones TH.
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):317-25. PubMed ID: 11298083
    [Abstract] [Full Text] [Related]

  • 6. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y, Sakamoto A, Satio T, Kawauchi S, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
    Szadowska A, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    Pol J Pathol; 1998 Sep; 49(1):15-21. PubMed ID: 9640970
    [Abstract] [Full Text] [Related]

  • 8. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V, Sørensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM.
    Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
    [Abstract] [Full Text] [Related]

  • 9. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Jun; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 10. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
    Würl P, Meye A, Schmidt H, Lautenschläger C, Kalthoff H, Rath FW, Taubert H.
    Oncogene; 1998 Mar 05; 16(9):1183-5. PubMed ID: 9528860
    [Abstract] [Full Text] [Related]

  • 11. Prognostic relevance of C-terminal Mdm2 detection is enhanced by p53 positivity in soft tissue sarcomas.
    Würl P, Meye A, Berger D, Bache M, Lautenschläger C, Schmidt H, Kalthoff H, Rath FW, Taubert H.
    Diagn Mol Pathol; 1997 Oct 05; 6(5):249-54. PubMed ID: 9458382
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
    Kanavaros P, Stefanaki K, Rontogianni D, Darivianaki K, Vlychou M, Papadaki E, Eliopoulos G, Bakiri M, Matsouka C, Kakolyris S, Georgoulias V.
    Clin Exp Pathol; 1999 Oct 05; 47(5):231-8. PubMed ID: 10598372
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.
    Shiina H, Igawa M, Shigeno K, Yamasaki Y, Urakami S, Yoneda T, Wada Y, Honda S, Nagasaki M.
    Oncology; 1999 Apr 05; 56(3):239-47. PubMed ID: 10202280
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours.
    Kindblom LG, Ahldén M, Meis-Kindblom JM, Stenman G.
    Virchows Arch; 1995 Apr 05; 427(1):19-26. PubMed ID: 7551341
    [Abstract] [Full Text] [Related]

  • 15. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
    Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF.
    Clin Cancer Res; 2000 Apr 05; 6(4):1279-87. PubMed ID: 10778952
    [Abstract] [Full Text] [Related]

  • 16. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
    Adachi T, Oda Y, Sakamoto A, Saito T, Tamiya S, Masuda K, Tsuneyoshi M.
    Int J Surg Pathol; 2001 Apr 05; 9(2):99-109. PubMed ID: 11484509
    [Abstract] [Full Text] [Related]

  • 17. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ.
    Cancer Res; 1994 Feb 01; 54(3):794-9. PubMed ID: 8306343
    [Abstract] [Full Text] [Related]

  • 18. Differential diagnosis of atypical epithelium of biopsied gastric mucosa using immunostaining of Ki-67, p53, hMLH1 and MDM2 expression.
    Ito E, Saito K, Takizawa T, Koike M.
    J Exp Clin Cancer Res; 2002 Dec 01; 21(4):527-37. PubMed ID: 12636099
    [Abstract] [Full Text] [Related]

  • 19. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery.
    Bode-Lesniewska B, Zhao J, Speel EJ, Biraima AM, Turina M, Komminoth P, Heitz PU.
    Virchows Arch; 2001 Jan 01; 438(1):57-65. PubMed ID: 11213836
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.